Mylan Inc. Gets OK to Acquire Injectables Business
Published: Sep 04, 2013
Mylan Inc. has cleared another hurdle in its planned acquisition of an Indian pharmaceutical company. The Southpointe-based Mylan (Nasdaq: MYL) said it received approval from the Foreign Investment Promotion Board of India for its plan to acquire the Agila injectables business from Strides Arcolab Ltd. It plans to finish the $1.6 billion purchase sometime in the fourth quarter. Help employers find you! Check out all the jobs and post your resume.